GE HealthCare is trading at $74.67, up 12.68%, after Needham initiated coverage with a Buy rating.

  • Needham set a $93 price target, implying 43% upside from September 21’s close.
  • The firm cited attractive risk-reward and expected Advanced Instrumentation Systems growth to accelerate during 2027.
  • GE HealthCare has recently faced earnings misses and supply constraints, making the bullish turnaround thesis notable.